National Research/$NRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About National Research
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Ticker
$NRC
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
368
ISIN
US6373722023
Website
NRC Metrics
BasicAdvanced
$384M
16.51
$1.02
0.36
$0.48
2.85%
Price and volume
Market cap
$384M
Beta
0.36
52-week high
$27.07
52-week low
$9.76
Average daily volume
87K
Dividend rate
$0.48
Financial strength
Current ratio
0.54
Quick ratio
0.366
Long term debt to equity
197.725
Total debt to equity
221.721
Dividend payout ratio (TTM)
46.74%
Interest coverage (TTM)
12.15%
Profitability
EBITDA (TTM)
41.204
Gross margin (TTM)
60.27%
Net profit margin (TTM)
17.13%
Operating margin (TTM)
24.83%
Effective tax rate (TTM)
24.85%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
17.13%
Return on equity (TTM)
72.69%
Valuation
Price to earnings (TTM)
16.509
Price to revenue (TTM)
2.798
Price to book
12.93
Price to tangible book (TTM)
-10.52
Price to free cash flow (TTM)
26.468
Free cash flow yield (TTM)
3.78%
Free cash flow per share (TTM)
63.62%
Dividend yield (TTM)
2.85%
Forward dividend yield
2.85%
Growth
Revenue change (TTM)
-4.15%
Earnings per share change (TTM)
-17.82%
3-year revenue growth (CAGR)
-2.17%
10-year revenue growth (CAGR)
3.61%
3-year earnings per share growth (CAGR)
-10.86%
10-year earnings per share growth (CAGR)
4.49%
3-year dividend per share growth (CAGR)
-7.17%
10-year dividend per share growth (CAGR)
14.87%
Bulls say / Bears say
NRC Health's recent partnerships with healthcare providers like UofL Health and Renown Health aim to enhance patient and employee experiences, potentially leading to increased client retention and revenue growth. (businesswire.com, businesswire.com)
The appointment of Trent Green as CEO in March 2025 brings experienced leadership, which may drive strategic initiatives and operational improvements. (businesswire.com)
NRC Health's recognition as the #1 Best in KLAS for Healthcare Experience Management in February 2025 enhances its reputation, potentially attracting new clients and strengthening market position. (businesswire.com)
NRC Health reported a decline in revenue for Q2 2024, with $35.02 million compared to $36.16 million in Q2 2023, indicating potential challenges in maintaining sales growth. (marketinference.com)
The company's net income decreased by 19.97% in 2024, reflecting potential profitability issues. (stockanalysis.com)
NRC Health's stock price has experienced significant volatility, with a 54.49% decline in 2024, raising concerns about investor confidence and market stability. (alphacubator.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
NRC Financial Performance
Revenues and expenses
NRC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jul11
National Research
Dividend·Payment
$0.12Per share
FAQs
What’s the current market cap for National Research stock?
National Research (NRC) has a market cap of $384M as of June 27, 2025.
What is the P/E ratio for National Research stock?
The price to earnings (P/E) ratio for National Research (NRC) stock is 16.51 as of June 27, 2025.
Does National Research stock pay dividends?
Yes, the National Research (NRC) stock pays dividends to shareholders. As of June 27, 2025, the dividend rate is $0.48 and the yield is 2.85%. National Research has a payout ratio of 46.74% on a trailing twelve-month basis.
When is the next National Research dividend payment date?
The next National Research (NRC) dividend payment is scheduled for July 11, 2025.
What is the beta indicator for National Research?
National Research (NRC) has a beta rating of 0.36. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.